Effects of allergic inflammation of the nasal mucosa on the severity of rhinovirus 16 cold

Journal of Allergy and Clinical Immunology

Volumn 105, Issue 5, 2000, Pages 923-932

  Avila, Pedro C ^b   Abisheganaden, John A ^b   Wong, Hofer ^a   Liu, Jane ^a   Yagi, Shigeo ^c   Schnurr, David ^c   Kishiyama, Jeffrey L ^b   Boushey, Homer A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VIRAL AND RICKETTSIAL DISEASE LABORATORY   (United States)

Author keywords

Allergic rhinitis; Common colds; Nasal allergen challenge; Rhinovirus

Indexed keywords

ALLERGEN; INTERLEUKIN 6; INTERLEUKIN 8;

ADULT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; MALE; NOSE MUCUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOVIRUS; SCORING SYSTEM; SPIROMETRY; VIRUS INFECTION;

EID: 0012813036     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2000.106214     Document Type: Article

References (48)

1. 1. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993;307:982-6.
2. 2. Johnston SL, Pattemore PK, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995;310:1225-9.
3. 3. Folkerts G, Busse WW, Nijkamp FP, Sorkness R, Gern JE. Virus-induced airway hyperresponsiveness and asthma. Am J Respir Crit Care Med 1998;157:1708-20.
4. 4. Fleming HE, Little FF, Schnurr D, et al. Rhinovirus-16 colds in healthy and asthmatic subjects: similar changes in upper and lower airways. Am J Respir Crit Care Med 1999;160:100-8.
5. 5. Empey DW, Laitinen LA, Jacobs L, Gold WM, Nadel JA. Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am Rev Respir Dis 1976;113:131-9.
6. 6. Lemanske RF Jr, Dick EC, Swenson CA, Vrtis RF, Busse WW. Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest 1989;83:1-10.
7. 7. Calhoun WJ, Swenson CA, Dick EC, Schwartz LB, Lemanske RF Jr, Busse WW. Experimental rhinovirus 16 infection potentiates histamine release after antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis 1991;144:1267-73.
8. 8. Fraenkel DJ, Bardin PG, Sanderson G, Lampe F, Johnston SL, Holgate ST. Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am J Respir Crit Care Med 1995;151:879-86.
9. 9. Trigg CJ, Nicholson KG, Wang JH, et al. Bronchial inflammation and the common cold: a comparison of atopic and non-atopic individuals. Clin Exp Allergy 1996;26:665-76.
10. 10. Grunberg K, Timmers MC, Smits HH, et al. Effect of experimental rhinovirus 16 colds on airway hyperresponsiveness to histamine and interleukin-8 in nasal lavage in asthmatic subjects in vivo. Clin Exp Allergy 1997;27:36-45.
11. 11. Cheung D, Dick EC, Timmers MC, de Klerk EP, Spaan WJ, Sterk PJ. Rhinovirus inhalation causes long-lasting excessive airway narrowing in response to methacholine in asthmatic subjects in vivo. Am J Respir Crit Care Med 1995;152:1490-6.
12. 12. Calhoun WJ, Dick EC, Schwartz LB, Busse WW. A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. J Clin Invest 1994;94:2200-8.
13. 13. Halperin SA, Eggleston PA, Beasley P, et al. Exacerbations of asthma in adults during experimental rhinovirus infection. Am Rev Respir Dis 1985;132:976-80.
14. 14. Angelini B, Van Deusen MA, Doyle WJ, Seroky J, Cohen S, Skoner DP. Lower airway responses to rhinovirus-Hanks in healthy subjects with and without allergy. J Allergy Clin Immunol 1997;99:618-9.
15. 15. Skoner DP, Doyle WJ, Seroky J, Fireman P. Lower airway responses to influenza A virus in healthy allergic and nonallergic subjects. Am J Respir Crit Care Med 1996;154:661-4.
16. 16. Skoner DP, Doyle WJ, Seroky J, Van Deusen MA, Fireman P. Lower airway responses to rhinovirus 39 in healthy allergic and nonallergic subjects. Eur Respir J 1996;9:1402-6.
17. 17. Grunberg K, Kuijpers EA, de Klerk EP, et al. Effects of experimental rhinovirus 16 infection on airway hyperresponsiveness to bradykinin in asthmatic subjects in vivo. Am J Respir Crit Care Med 1997;155:833-8.
18. 18. Summers QA, Higgins PG, Barrow IG, Tyrrell DA, Holgate ST. Bronchial reactivity to histamine and bradykinin is unchanged after rhinovirus infection in normal subjects. Eur Respir J 1992;5:313-7.
19. 19. Alper CM, Doyle WJ, Skoner DP, et al. Prechallenge antibodies: moderators of infection rate, signs, and symptoms in adults experimentally challenged with rhinovirus type 39. Laryngoscope 1996;106:1298-305.
20. 20. Coyle AJ, Erard F, Bertrand C, Walti S, Pircher H, Le Gros G. Virus-specific CD8+ cells can switch to interleukin 5 production and induce airway eosinophilia. J Exp Med 1995;181:1229-33.
21. 21. Coyle AJ, Bertrand C, Tsuyuki S, et al. IL-4 differentiates naive CD8+ T cells to a "Th2-like" phenotype: a link between viral infections and bronchial asthma. Ann N Y Acad Sci 1996;796:97-103.
22. 22. Greve JM, Davis G, Meyer AM, et al. The major human rhinovirus receptor is ICAM-I. Cell 1989;56:839-47.
23. 23. Altman LC, Ayars GH, Baker C, Luchtel DL. Cytokines and eosinophil-derived cationic proteins upregulate intercellular adhesion molecule-1 on human nasal epithelial cells. J Allergy Clin Immunol 1993;92:527-36.
24. 24. Bianco A, Spiteri MA. A biological model to explain the association between human rhinovirus respiratory infections and bronchial asthma. Monaldi Arch Chest Dis 1998;53:83-7.
25. 25. Gern JE, Calhoun W, Swenson C, Shen G, Busse WW. Rhinovirus infection preferentially increases lower airway responsiveness in allergic subjects. Am J Respir Crit Care Med 1997;155:1872-6.
26. 26. Bardin PG, Fraenkel DJ, Sanderson G, et al. Amplified rhinovirus colds in atopic subjects. Clin Exp Allergy 1994;24:457-64.
27. 27. Fraenkel DJ, Bardin PG, Sanderson G, Lampe F, Johnston SL, Holgate ST. Immunohistochemical analysis of nasal biopsies during rhinovirus experimental colds. Am J Respir Crit Care Med 1994;150:1130-6.
28. 28. Jackson GG, Dowling HF, Spiesman IG, Boand AV. Transmission of the common cold to volunteers under controlled conditions, I: the common cold as a clinical entity. Arch Intern Med 1958;101:267-78.
29. 29. Janson-Bjerklie S, Shnell S. Effect of peak flow information on patterns of self-care in adult asthma. Heart Lung 1988;17:543-9.
30. 30. O'Connor G, Sparrow D, Taylor D, Segal M, Weiss S. Analysis of dose-response curves to methacholine: an approach suitable for population studies. Am Rev Respir Dis 1987;136:1412-7.
31. 31. Gwaltney JM Jr, Hendley O, Hayden FG, et al. Updated recommendations for safety-testing of viral inocula used in volunteer experiments on rhinovirus colds. Prog Med Virol 1992;39:256-63.
32. 32. Knight V. The use of volunteers in medical virology. Prog Med Virol 1964;6:1-26.
33. 33. Bush RK, Busse W, Flaherty D, Warshauer D, Dick EC, Reed CE. Effects of experimental rhinovirus 16 infection on airways and leukocyte function in normal subjects. J Allergy Clin Immunol 1978;61:80-7.
34. 34. Robinson PJ, Hegele RG, Schellenberg RR. Allergic sensitization increases airway reactivity in guinea pigs with respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol 1997;100:492-8.
35. 35. Papadopoulos NG, Sanderson G, Hunter J, Johnston SL. Rhinoviruses replicate effectively at lower airway temperatures. J Med Virol 1999;58:100-4.
36. 36. Tsicopoulos A, Hamid Q, Haczku A, et al. Kinetics of cell infiltration and cytokine messenger RNA expression after intradermal challenge with allergen and tuberculin in the same atopic individuals. J Allergy Clin Immunol 1994;94:764-72.
37. 37. Harris JM, Gwaltney JM Jr. Incubation periods of experimental rhinovirus infection and illness. Clin Infect Dis 1996;23:1287-90.
38. 38. Doyle WJ, Skoner DP, Fireman P, et al. Rhinovirus 39 infection in allergic and nonallergic subjects. J Allergy Clin Immunol 1992;89:968-78.
39. 39. Martin U, Bryden K, Devoy M, Howarth P. Increased levels of exhaled nitric oxide during nasal and oral breathing in subjects with seasonal rhinitis. J Allergy Clin Immunol 1996;97:768-72.
40. 40. Garrelds IM, van Amsterdam JG, de Graaf-in't Veld C, Gerth van Wijk R, Zijlstra FJ. Nitric oxide metabolites in nasal lavage fluid of patients with house dust mite allergy. Thorax 1995;50:275-9.
41. 41. Kharitonov SA, O'Connor BJ, Evans DJ, Barnes PJ. Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. Am J Respir Crit Care Med 1995;151:1894-9.
42. 42. Sanders SP, Siekierski ES, Porter JD, Richards SM, Proud D. Nitric oxide inhibits rhinovirus-induced cytokine production and viral replication in a human respiratory epithelial cell line. J Virol 1998;72:934-42.
43. 43. Domachowske JB, Dyer KD, Adams AG, Leto TL, Rosenberg HF. Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity. Nucleic Acids Res 1998;26:3358-63.
44. 44. Noah TL, Henderson FW, Wortman IA, et al. Nasal cytokine production in viral acute upper respiratory infection of childhood. J Infect Dis 1995;171:584-92.
45. 45. Zhu Z, Tang W, Ray A, et al. Rhinovirus stimulation of interleukin-6 in vivo and in vitro: evidence for nuclear factor kappa B-dependent transcriptional activation. J Clin Invest 1996;97:421-30.
46. 46. Teran LM, Johnston SL, Schroder JM, Church MK, Holgate ST. Role of nasal interleukin-8 in neutrophil recruitment and activation in children with virus-induced asthma. Am J Respir Crit Care Med 1997;155:1362-6.
47. 47. Turner RB, Weingand KW, Yeh CH, Leedy DW. Association between interleukin-8 concentration in nasal secretions and severity of symptoms of experimental rhinovirus colds. Clin Infect Dis 1998;26:840-6.
48. 48. Hendley JO. The host response, not the virus, causes the symptoms of the common cold. Clin Infect Dis 1998;26:847-8.